July 15, 2025

U.S. Children’s Health Worsens Over 17 Years

A new study analyzing over a decade of national health surveys, electronic records, and international data shows a consistent rise in chronic conditions, obesity, emotional symptoms, and mortality rates among children and adolescents in the U.S..

Conexiant

July 15, 2025

New Autism Classes Highlight Genetic Underpinnings

Researchers identified four distinct autism subtypes with unique genetic profiles and developmental patterns.

Conexiant

July 10, 2025

1 in 4 U.S. Infants Missing Bifidobacterium: Study

Babies who lacked this key gut bacteria were at an increased risk of eczema, allergies, and asthma by age 2.

Conexiant

July 08, 2025

Natural Cycle Beats HRT in FET Outcomes

A randomized trial found that using a natural cycle to prepare the endometrium for frozen embryo transfer in ovulatory women led to higher live birth rates and fewer complications compared to hormone replacement therapy.

Conexiant

July 07, 2025

FDA Approves First Oral Hereditary Angioedema Treatment

FDA approves Ekterly (sebetralstat), the first oral on-demand treatment for hereditary angioedema, shown in trials to provide faster symptom relief and eliminate the need for injection.

Conexiant

July 07, 2025

Early Sepsis in Newborns Linked to Autism Risk

A large Danish study found that newborns with early-onset sepsis had a higher chance of developing autism later in life, while the link to ADHD was weaker when familial factors were considered.

Conexiant

July 07, 2025

Newborns Show Higher p-tau217 Than Alzheimer’s Patients

Newborns have higher levels of phosphorylated tau217 in their blood than even patients with Alzheimer’s disease, a new study finds, raising new questions about the dual role of tau in brain development and degeneration.

Conexiant

July 02, 2025

Medical Oddities: Leprosy’s Old New World Secret

This week’s clinical grab bag: tea for gloom, ancient leprosy, smoggy fibrosis & power peeing.

Conexiant

July 02, 2025

Gel Offers Relief for Axillary Sweating 

A pooled analysis of two phase 3 trials found that a once-daily topical anticholinergic gel significantly improved sweat reduction and symptom severity in patients with axillary hyperhidrosis, with a tolerable safety profile.

Conexiant